Picture of Chunghwa Chemical Synthesis & Biotech Co logo

1762 Chunghwa Chemical Synthesis & Biotech Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line144650498583333
Depreciation
Amortisation
Non-Cash Items-16.7-385-31.9-73.1-36.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital11.4-259-37954.6-557
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities268138219734-66.3
Capital Expenditures-115-193-405-376-452
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1541,058-3970-9.77
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-269865-803-376-461
Financing Cash Flow Items-0.126-0.14-0.333-0.279
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-3.5-955631-253497
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.1547.446.6105-31